Skip to main content
. 2021 Sep 28;97(13):e1334–e1342. doi: 10.1212/WNL.0000000000012603

Figure. Percentage of Trial Participants With Contrast-Enhancing Lesions (CELs) by Age Group.

Figure

Percentage of trial participants with CELs by age group at baseline in the 4 included trial datasets. The percentage of individuals with CELs decreases as a function of age and disease course both at baseline and after 1 year of treatment.